新闻
TTPH
--
0.00%
--
新股消息丨临床后期生物制药公司云顶新耀过聆讯 开发药物覆盖肿瘤、免疫学、心肾疾病及感染性疾病
智通财经网 · 2020/09/20 23:55
The Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy
Benzinga · 2020/06/25 13:26
The Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24)
Benzinga · 2020/06/25 12:26
Tetraphase Terminated Deal With Melinta
Benzinga · 2020/06/24 11:38
UPDATE: Total Value Of La Jolla Purchase Of Tetraphase $43M In Upfront Cash Plus Potential Future Cash Payments Of Up To $16M
Benzinga · 2020/06/24 11:33
UPDATE: Tetraphase Shareholders Will Be Entitled To Receive 1 Non-Tradeable Contingent Value Right
Tetraphase equity holders would also be entitled to receive, for each share of Tetraphase common stock, one non-tradeable CVR. The holders of the CVRs would be entitled to receive payments of up to an additional $16.0
Benzinga · 2020/06/24 11:32
La Jolla Pharma To Purchase Tetraphase Pharma For Upfront Payment Of $2/Share Of Tetraphase Common Stock, $2.68/Share Of Tetraphase Stock Underlying Nov. 2019 Warrants , $2.69/Share Tetraphase Stock Underlying Jan. 2020 Warrants
Benzinga · 2020/06/24 11:31
La Jolla Pharmaceutical Rekindles Interest In Tetraphase With Sweetened Offer
Benzinga · 2020/06/22 17:14
La Jolla Pharmaceutical Rekindles Interest In Tetraphase With Sweetened Offer
The bidding war for Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH) seems to be far from over.
Benzinga · 2020/06/22 16:14
Tetraphase Pharma Receives an Acquisition Offer From La Jolla Pharma, Tetraphase Board Continues to Recommend Merger with Melinta
Under the Melinta Merger Agreement, Melinta would acquire Tetraphase through a cash tender offer by its subsidiary for all of Tetraphase’s outstanding shares of common stock, for an aggregate of $39.0 million in
Benzinga · 2020/06/22 10:10
The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset
Benzinga · 2020/06/10 12:30
Tetraphase Pharma 8-K Shows FDA Approved Supplemental New Drug Application For New Strength Of XERAVA For Injection As Treatment For Complicated Intra-Abdominal Infections
Benzinga · 2020/06/05 10:22
UPDATE: Tetraphase Pharmaceutical Shares Up 4% After Resumption Of Trading
Benzinga · 2020/06/04 13:54
Tetraphase Pharmaceuticals Shares Resume Trading, Previously Halted On News Pending
Benzinga · 2020/06/04 13:51
UPDATE: Melinta To Buy Tetraphase For $1.79/Tetraphase Shares, $2.47/Share Of Of Underlying Warrants
Benzinga · 2020/06/04 13:34
UPDATE: Melinta To Purchase Tetraphase For $39M In Cash Plus Added $16M In Cash Potentially Payable Under Contingent Value Rights
Benzinga · 2020/06/04 13:33
Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals
Tetraphase terminates merger agreement with AcelRx to enter into merger agreement with Melinta Melinta agreement provides for an aggregate of $39.0 million upfront in cash plus potential contingent value
Benzinga · 2020/06/04 13:23
The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic
Benzinga · 2020/06/04 13:13
Tetraphase Pharma Shares Halted News Pending
Benzinga · 2020/06/04 12:55
The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peak (Biotech Stocks Hitting 52-week Highs June 3)
Benzinga · 2020/06/04 12:13
微牛提供丰富的实时TTPH股票新闻,让你可以通过多个平台了解TTPH股票行情最新动态,这些免费的Tetraphase制药新闻可以帮助你做出明智投资。
TTPH 简况
Tetraphase Pharmaceuticals, Inc.是一家临床阶段的生物制药公司。该公司使用其化学技术为多重抗药性感染制造抗生素。该公司正在开发的先导候选产品eravacycline是一种全合成的四环素类衍生物。eravacycline作为一种光谱静脉注射(IV)和口服抗生素,是一种用于治疗多重耐药性感染的首要经验性单药疗法。该公司还开发用于治疗多重抗药性革兰氏阴性菌的TP-6076。Eravacycline是一种氟环素抗生素。该公司正在为eravacycline开展名为Investigating Gram-Negative Infections Treated with Eravacycline(IGNITE)的全球III期临床计划。TP-271是一种正处于开发阶段的全合成氟环丁烷,用于治疗健康志愿者由细菌性生物威胁病原体引起的呼吸道疾病。